High dose thiotepa
Web17 de jul. de 2014 · Although full consensus has not been reached within the HCT community, conditioning regimens have been classified as high-dose (myeloablative), reduced-intensity, and nonmyeloablative, following the Reduced-Intensity Conditioning Regimen Workshop, convened by the Center for International Blood and Marrow … WebBackground: Autologous stem cell transplantation (ASCT) generally provides good results in Hodgkin's lymphoma (HL). We studied a high-dose chemotherapy regimen based on …
High dose thiotepa
Did you know?
WebSince, IOV of both thioTEPA and TEPA was equal to or smaller than IIV, therapeutic drug monitoring based on data of previous courses may be meaningful using this population model. AIMS To study the population pharmacokinetics of thioTEPA and its main metabolite TEPA in patients receiving high-dose chemotherapy consisting of thioTEPA (80-120 mg … Web20 de out. de 2024 · Very few prospective studies have been conducted in this patient group. This study was a multicenter phase 1/2 study that investigated thiotepa in combination with ifosfamide, etoposide, and rituximab (TIER) for the treatment of PCNSL relapsed or refractory to high-dose methotrexate-based chemotherapy.
WebHigh-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, … WebProspective studies of intensive chemotherapy regimens containing high-dose methotrexate, followed by hematopoietic stem cell transplantation have shown the most favorable outcomes, especially for patients receiving thiotepa-based …
Web2 de nov. de 2015 · No toxicity-related death was associated with high-dose (HD) thiotepa. The median hospital stay was 24 days (range 19–49). HD busulfan–melphalan (n=24) WebHigh-dose thioTEPA is used frequently in myeloablative regimens for marrow transplantation, but the need for dose adjustments in obese patients has not been …
Web19 de abr. de 2004 · Children with high-risk and recurrent brain tumors currently have a poor prognosis. 1-5 To increase brain distribution of antitumor drugs that do not cross the …
Web21 de set. de 2024 · Thiotepa side effects. Get emergency medical help if you have signs of an allergic reaction: hives; wheezing, difficult breathing; swelling of your face, lips, … can cats get meningitisWeb19 de abr. de 2004 · Children with high-risk and recurrent brain tumors currently have a poor prognosis. 1-5 To increase brain distribution of antitumor drugs that do not cross the blood-brain barrier at conventional dosages and to achieve higher concentrations within the tumor, high-dose chemotherapy (HDCT) followed by autologous hemopoietic stem cell … can cats get lyme disease from fleasWeb21 de set. de 2016 · Alkylating agents have been shown to be active against both CNS and systemic GCTs 27 and given that their dose-limiting toxicity is primarily hematologic, these are attractive agents for high-dose therapy followed by ASCR. Thiotepa, 28 specifically, has been shown to cross the blood-brain barrier extremely efficiently and has a mild … can cats get mercury poisoning from tunaWeb15 de ago. de 2024 · High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with … can cats get meningitis from humansWeb21 de set. de 2016 · Stewart DA, Forsyth P, Chaudhry A, et al: High dose thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic stem cell transplantation (ASCT) without whole brain radiotherapy (WBRT) for primary central nervous system lymphoma (PCNSL). Blood (ASH Annual Meeting Abstracts) 104:: 4315, 2004, (abstr … can cats get mites from birdsWebPrzepiorka D, Nath R, Ippoliti C, Mehra R, Hagemeister F, Diener K, Dimopoulos M, et al. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma. Leuk Lymphoma. 1995; 17:427–33. [Abstract: 7549833] fishing postersWeb9 de set. de 2014 · Therefore, high-dose rituximab was combined with TBC for ASCT in patients with CNS NHL. METHODS. A single-arm phase 2 trial using high-dose rituximab with cytarabine for stem cell mobilization followed by high-dose rituximab combined with thiotepa, busulfan, and cyclophosphamide (R-TBC) for ASCT was conducted. fishingpost